Author

M. Shinkai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein structure prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

T. Matsumura· 2 shared T. Onodera· 2 shared Y. Takahashi· 2 shared A. Nishiyama· 1 shared D. Motooka· 1 shared E. E. Nakayama· 1 shared E. Ishikawa· 1 shared F. Nakamura-Uchiyama· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

T. Matsumura

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Two doses of mRNA vaccine elicit cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant

R. Kotaki, Y. Adachi, S. Moriyama, T. Onodera, S. Fukushi, T. Nagakura, K. Tonouchi, K. Terahara, L. Sun, T. Takano, A. Nishiyama, M. Shinkai, K. Oba, F. Nakamura-Uchiyama, H. Shimizu, , Y. Takahashi

The paper shows that two doses of mRNA vaccine generate cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant, which are retained and contribute to enhanced antibody responses after a third dose.

bioRxiv · Dec 24, 2021 · PreprintImmunology

Identification, crystallization and epitope determination of public TCR shared and expanded in COVID-19 patients

X. Lu, Y. Hosono, S. Ishizuka, M. Nagae, E. Ishikawa, D. Motooka, Y. Ozaki, N. Sax, R. Shinnakasu, T. Inoue, T. Onodera, T. Matsumura, M. Shinkai, T. Sato, S. Nakamura, , S. Yamasaki

The paper identifies and crystallizes public TCRs from SARS-CoV-2-specific Tfh cells in COVID-19 patients, showing they recognize conserved spike epitopes and cross-react with symbiotic bacteria.

bioRxiv · Mar 23, 2021Immunology